GSK plc Share Buyback Program Update

GSK plc announced the purchase of 166,000 of its ordinary shares on 27 October 2025 as part of its existing buyback program. The shares were purchased through BNP Paribas SA, with prices ranging from 1,632.50p to 1,645.00p per share, and a volume-weighted average price of 1,637.64p. Following this purchase, GSK holds 253,913,344 ordinary shares in treasury, with 4,061,507,442 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the company is 4,061,507,442, and the percentage of voting rights attributable to treasury shares is 6.25%. This buyback is part of the non-discretionary agreement announced on 30 September 2025, under which GSK has purchased a total of 6,448,500 ordinary shares since then.